Talk:Signal-regulatory protein alpha

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Move suggestion[edit]

Any objections to move this to CD172A? The term SIRPa seems to be more generic (see [1] for an example of a different use). --Waldir ^talk 19:05, 27 March 2012 (UTC)[reply]

AFAICS CD172A and SIRPA are 2 terms describing exactly the same entity. See here: http://www.ncbi.nlm.nih.gov/gene/140885 SIRPa seems to be the most commonly used form. CD172a seems to be rarely used, especially in the context of the Trillium / Stanford / Weissman and Celgene InhibRx cancer treatment research. The link you have given to the Weissman paper does not mention CD172a at all. — Preceding unsigned comment added by 88.209.93.50 (talk) 09:54, 11 July 2015 (UTC)[reply]

Poorly written[edit]

The English used is poor. This sentence for example:

Cancer cell highly expressed CD47 that activate SIRP α and inhibit macrophage-mediated destruction.

doesn't have a main verb, so is incomprehensible. — Preceding unsigned comment added by 88.209.93.50 (talk) 09:26, 11 July 2015 (UTC)[reply]

Wrong protein diagram in infobox[edit]

infobox at top right shows CD47 not any part of SIRP-alpha ! - Rod57 (talk) 13:47, 8 February 2017 (UTC)[reply]